Omalizumab for chronic urticaria in Latin America

Omalizumab for chronic urticaria in Latin America

Show other versions (1)

Abstract Background Chronic urticaria (CU) is defined as the spontaneous appearance of wheals, with or without angioedema, persisting for ≥6 weeks. Chronic Spontaneous Urticaria (CSU) is a type of CU which affects 0.5–1 % of the global population, but it represents a high burden to patients. In rece...

Full description

Bibliographic Details
Main Authors: Paul Wilches, Paola Wilches, Juan Carlos Calderon, Annia Cherrez, Ivan Cherrez Ojeda
Format: Article
Language:English
Published: Elsevier 2016-11-01
Series:World Allergy Organization Journal
Subjects:
Omalizumab
Chronic urticaria
Anti-IgE
Real life study
Latin America
Online Access:http://link.springer.com/article/10.1186/s40413-016-0127-y

Internet

http://link.springer.com/article/10.1186/s40413-016-0127-y

Similar Items